Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 38

Lightricks shines with $130m series D

The content creation tool developer was valued at $1.8bn through a series D round featuring Access Industries’ ClalTech unit, Harel Insurance and Finance and Migdal Insurance.

Sep 21, 2021

Discord receives $500m funding message

The Tencent and WarnerMedia-backed online messaging platform developer reportedly increased its valuation to $15bn in the round.

Sep 17, 2021

MPL wins $150m round

Mobile Premier League has pushed its valuation to $2.3bn, though none of its corporate backers elected to return for the latest round.

Sep 16, 2021

Daily Deal Round Up: September 15, 2021

Online furniture retailer Gaia, warehouse robot provider Locus Robotics, recruitment platform developer Canvas and ESG software producer Measurabl all raised $50m.

Sep 15, 2021

Investors help Canva paint $200m picture

The Vayner Capital-backed visual design tool provider has secured funding at a $40bn valuation, five months after a $71m round.

Sep 15, 2021

Daily Deal Round Up: September 14, 2021

Samsung-backed automation software developer Rezilion secured $30m while IGC Hospitality took part in restaurant management technology provider MarginEdge's $18m series B round.

Sep 14, 2021

Rising Stars Q&A – Will Geiger & Brett Kadesh, Touchdown Ventures

Q&A with Will Geiger & Brett Kadesh, principals, Touchdown Ventures

Sep 14, 2021

Jam City plays for $350m

The mobile game developer secured $350m from investors including Netmarble and Kabam and has closed the purchase of gaming studio Ludia.

Sep 13, 2021

Ximalaya descends from US offering

The Tencent-backed audio streaming platform developer cancelled its plans to float in New York after the Chinese authorities asked it to consider listing in Hong Kong.

Sep 13, 2021

Daily Deal Round Up: September 10, 2021

Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.

Sep 10, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here